$62.14
-0.99-1.57%
Last update: Nov 6, 7:16 PM
Bristol-Myers Squibb Co (BMY) Stock Price, Quote, News & History
BMYNYSE
Bristol-Myers beats Q3 2026 estimates with $13.07B in revenue and raises full-year sales guidance driven by newer drug growth.
You can purchase shares of Bristol-Myers Squibb (NYSE:BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Bristol-Myers Squibb has a consensus price target of $61.43.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $62.35 last updated November 6, 2026 at 7:16 PM EST.
There are no upcoming dividends for Bristol-Myers Squibb.
Bristol-Myers Squibb does not have any upcoming earnings scheduled.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol...
